Business Context and Reporting Period
This Form 8-K filing by RXi Pharmaceuticals Corporation (referred to as Phio Pharmaceuticals Corp. in metadata) covers events occurring on July 19, 2013, with a report date of July 22, 2013. The filing details a material corporate action involving a reverse stock split and a subsequent application for stock exchange listing.
Key Financial Metrics
The filing does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on corporate governance and capital structure adjustments.
Material Changes
- Reverse Stock Split: The Company effected a one-for-thirty reverse stock split of its issued and outstanding common stock, effective July 23, 2013, at 11:59 p.m. Eastern Time.
- Shareholder Approval: The split was unanimously approved by holders of Series A Convertible Preferred Stock at a special meeting on July 18, 2013, satisfying the requirement for 95% preferred stockholder approval.
- Adjustments to Equity Instruments: Outstanding options under the 2012 Long Term Incentive Plan were adjusted with a proportionate increase in exercise prices and a decrease in share counts. The conversion ratio for Series A Convertible Preferred Stock was also automatically adjusted.
- Fractional Shares: No fractional shares were issued; stockholders received cash for fractional amounts.
Guidance, Outlook, and Risks
- Listing Application: On July 22, 2013, the Company announced it has applied for listing on The NASDAQ Capital Market.
- Management Commentary: The filing notes that the reverse stock split does not alter the par value of the common stock or modify voting rights.
- Risks and Contingencies: The filing does not explicitly detail new risks or contingencies beyond the standard execution of the stock split and listing application.
Investor Verification Checklist
- Verify the effective date and time of the one-for-thirty reverse stock split (July 23, 2013, 11:59 p.m. ET).
- Confirm the status of the NASDAQ Capital Market listing application announced on July 22, 2013.
- Review the adjusted exercise prices and share counts for outstanding options under the 2012 Long Term Incentive Plan.
- Check the adjusted conversion ratio for Series A Convertible Preferred Stock.
- Confirm the cash payout mechanism for fractional shares resulting from the split.